Parnell Pharmaceuticals Holdings Announces $20 Million Secured Term Loan Facility Life Science Investing
Bristol-Myers Squibb Receives European Approval for Opdivo for the Treatment of Relapsed or Refractory Classical Hodgkin Lymphoma Biotech Investing
Acorda Discontinues Dalfampridine for Treatment of Post-Stroke Mobility Issues Life Science Investing